logo
Plus   Neg
Share
Email

Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen

Thermo Fisher Scientific Inc. (TMO), the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV (QGEN,QGENF), Bloomberg reported citing people familiar with the matter.

The Dutch company Qiagen, which is listed in New York and Frankfurt, has a market value of about $8 billion as of Wednesday's close.

There's no certainty the discussion will lead to a deal, and other bidders for Qiagen could emerge, the report said.

QGEN closed Wednesday regular trading at $35.45, up $3.19 or 9.89 percent. In the after-hours, the stock further gained $0.70 or 1.97 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla said it will produce ventilators at its Gigafactory in Buffalo, New York to support the city's hospitals amid the coronavirus pandemic. New York is the worst affected state in the U.S. Last Saturday, Musk tweeted that he "had a long engineering discussion with Medtronic about state-of-the-art ventilators. Luxury fashion house Ralph Lauren will donate $10 million to help fight the coronavirus pandemic and manufacture face masks as well as medical gowns in the U.S. The company's charity arm, the Ralph Lauren Corporate Foundation, said in a statement that it is committing $10 million towards the global response to the COVID-19 pandemic. General Motors Co. is delaying work on new vehicle models and is cutting pay for its executives as part of efforts to conserve cash amid the coronavirus or Covid-19 pandemic. The automotive giant also extended the shutdown of North American plants indefinitely. Multiple reports cited an internal memo that salaried workforce will have 20 percent of pay deferred starting April 1.
Follow RTT
>